Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera

Opinion
Video

Timothy Mok, PharmD, BCPS, BCOP, and Gabriela Hobbs, MD, introduce themselves and provide insights on the prevalence of hydroxyurea resistance or intolerance in patients with polycythemia vera (PV) and how it impacts treatment decisions and costs.

Recent Videos
2 experts are featured in this series.
2 experts in this video
2 experts in this video
1 expert in this video
2 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.